PolyPeptide Group / Key word(s): Personnel
01-Dec-2021 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Media Release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide Group appoints Neil Thompson as Director Global Sales and Marketing and member of the Executive Committee, succeeding Jan Christensen
Zug, December 1, 2021 – PolyPeptide Group AG, a global leader in peptide development and manufacturing, today announced the appointment of Neil Thompson as Director Global Sales and Marketing and member of the Executive Committee. As per 1 January 2022, he will succeed Jan Christensen, who will step down after 11 years in the role.
PolyPeptide CEO Raymond De Vré comments: “The two worked together over many years in customer facing roles. This internal succession ensures continuity and reflects well on our internal talent pool. I am excited that Neil accepted the new challenge, and I am grateful to Jan for his inspiring and exemplary leadership. Together with the sales and operations teams, Jan was instrumental in developing today’s leading position of PolyPeptide. I am convinced that with Neil’s unique mix of technical and sales experience, we are in an excellent position to capture the growth opportunities ahead of us.”
Neil James Thompson (49, British) joined PolyPeptide in 2004 and held various sales and business development roles, most recently, since 2019, as Group Commercial Director. He graduated from Liverpool John Moores University with a Bachelor of Science degree in Applied Chemistry and Biochemistry.
Jan Christensen (61, Danish) joined PolyPeptide in 2002 as Head of Generics Europe, then had various positions with increasing responsibilities. In 2010 he was appointed Director Global Sales and Marketing. After stepping down from his executive position in January 2022, Mr. Christensen will support selected business development projects before retiring towards the end of 2022.
End of ad hoc announcement
|Phone:||+41 41 723 23 23|
|Listed:||SIX Swiss Exchange|
|EQS News ID:||1253109|
|End of Announcement||EQS Group News Service|